MTSLead source
SITUATION DETECTED: Isomorphic Labs, Demis Hassabis’s AI drug-discovery spinout from Google DeepMind, is in early talks to raise at a valuation of at least $40 billion, and possibly $50 billion, per Bloomberg.Read original on X
StoryFirst seen
Isomorphic Labs in talks to raise at a $40 billion valuation
Demis Hassabis's AI drug-discovery spinout from Google DeepMind could command as much as $50 billion, per Bloomberg.
Archived Updated
Everything it touches
2 names 1 voices 1 source posts
The story’s neighborhood
NAMESVOICESPOSTS
Explore the graph, or choose a connection below.
Follow the evidence
The source posts
This brief comes from Tech Twitter’s edited headlines. The posts below are the sources grouped with the story; statements in them belong to their authors.
How the headline evolved
Isomorphic Labs in talks to raise at a $40 billion valuation
Isomorphic Labs in talks to raise at a $40 billion valuation
Isomorphic Labs seeks $40 billion valuation in funding talks
Shared connections
Related stories
Anthropic files to go public, disclosing $657 billion in compute commitments
The filing gives investors their first detailed look at the AI lab's finances and profitability.
Anthropic files publicly for Nasdaq IPO under ticker ANT
The filing gives investors their first detailed look at the AI lab's finances and cloud commitments.
Apple is adding touch to Macs as customers come to expect it
Apple has long refused touch on the Mac, so the change could reshape how Mac users interact with their laptops.
Google cleared Finnish forest for data center before environmental review
Finland had told Google in writing a review was needed, yet clearing continued until August.